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Abstract
Severity of illness scoring systems are useful for decisions on the management of patients with community-acquired pneumonia (CAP),
including assessing the need for intensiﬁed therapy and monitoring, or for intensive care unit (ICU) admission. We compared the accu-
racy of the Pneumonia Severity Index (PSI), the CURB-65 and CRB-65 score, the modiﬁed-American Thoracic Society score (ATS), the
IDSA/ATS guidelines and the Pitt Bacteraemia score (PBS) in evaluating severity of illness in 766 patients with bacteraemic pneumococ-
cal pneumonia. We evaluated the sensitivity and speciﬁcity, the positive predictive value (PPV) and the negative predictive value (NPV)
and the accuracy of the classiﬁcation in predicting 14-day mortality. The PSI and the IDSA/ATS guidelines were the most sensitive
whereas the PBS and modiﬁed-ATS scoring systems were the most speciﬁc in predicting mortality. The NPV was comparable for all
four scoring systems (all above 90%), but the PPV was highest for PBS (54.2%) and lowest for PSI (23.2%). The predictive accuracy and
discriminating power as measured by the receiver-operating characteristic (ROC) curve was highest for the PBS. Both the modiﬁed-
ATS and the PBS scoring systems identiﬁed those patients who might beneﬁt most from intensiﬁed care and monitoring. The PBS and
modiﬁed-ATS proved superior to the IDSA/ATS guidelines, CURB-65 and CRB-65 with respect to their speciﬁcity and PPV. The low
PPV of the PSI rendered it not usable as a parameter for decision-making in severely-ill patients with pneumococcal bacteraemia.
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Severity of illness (SOI) plays a major role in determining the
site of care, the diagnostic workup and the empirical choice
of antibiotics for patients with community-acquired pneumo-
nia (CAP) [1]. A number of scoring systems have been devel-
oped for evaluation of the severity of infection. We
compared the accuracy of the Pneumonia Severity Index
(PSI) [2], the CURB-65 scoring system [3], the CRB-65 scor-
ing system without the uraemia factor [4], the modiﬁed-
American Thoracic Society (ATS) scoring system [5], the
IDSA/ATS guidelines [6] and the Pitt Bacteremia Score (PBS)
[7] in evaluating severity of illness in patients with bacterae-
mic pneumococcal pneumonia. Our objective was to assess
which scoring system would be most accurate in selecting
patients at high risk for mortality and who might beneﬁt
from treatment in the intensive care unit (ICU).
Methods
Study sites and patients
Study design. We analysed data collected from a prospective
observational study of 844 patients with bacteraemic
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pneumococcal disease from 21 hospitals in ten countries [8].
Institutional review board approval was obtained from all
sites in accordance with their local requirements. We
excluded patients who also had meningitis (59 patients) and
endocarditis (seven patients), those whose ICU status was
uncertain (nine patients) and those whose mental status was
not evaluated (three patients). Thus, 766 cases of radiologi-
cally-conﬁrmed pneumonia associated with pneumococcal
bacteraemia were evaluated.
Patients were deﬁned as ‘severely-ill’ for a PBS of >4, a
PSI of IV or V and a CURB-65 score ‡3 (Table 1). The modi-
ﬁed-ATS score of 2 minor criteria or 1 major criterion was
considered to indicate ‘severely-ill’ (Table 1). The IDSA/ATS
guidelines of 3 minor criteria or 1 major criterion was con-
sidered to indicate ‘severely-ill’ (Table 1). Missing laboratory
parameter values were considered as normal values where
feasible. Twenty-seven patients did not have their age
recorded. To minimize biases from missing data, we also
assessed a subgroup of patients in whom there were no
missing values (n = 519) for any of the scoring systems. The
endpoints were 14-day and 30-day mortality.
Statistical analysis
We evaluated the sensitivity, speciﬁcity, positive predictive
value (PPV) and negative predictive value (NPV) as well as
the accuracy of classiﬁcation of 14-day and 30-day mortality
for each SOI scoring system. We calculated the area under
the receiver-operating characteristic (ROC) curve for each
SOI scoring system; 95% conﬁdence intervals were calculated




The number of patients varied for each score depending on
the number of parameters evaluable: PBS (766 patients),
modiﬁed-ATS criteria (766 patients), IDSA/ATS guidelines
(766 patients), CURB-65 and CRB-65 (744 patients) and PSI
(742 patients). Overall 739 patients were evaluable for all
scoring systems if normal values were substituted for missing
laboratory parameters. When patients with any missing
parameter were excluded, 519 patients were available for
evaluation.
Predictive accuracy
The PSI had the highest sensitivity (80.2%) whereas the PBS
had the highest speciﬁcity (91.3%) and positive predictive
value (PPV) (54.2%) (Table 2). All scoring systems had
respectable NPVs (over 90%) (Tables 2 and 3). Analyses of
only the 519 patients in whom all SOI parameters were
available gave similar results to those for the larger groups
in the case of each individual SOI score (Table 3).
Discriminatory power
The PBS had a signiﬁcantly higher discriminatory power as
measured by ROC curve than any of the other scores
(four-way comparison, p <0.05, data not shown). There
was no signiﬁcant difference in discriminatory power
TABLE 1. Calculation parameters of the PBS, modiﬁed-






PBS Fever (oral temperature) >4 [7]
£35C or ‡40C 2
35.1–36.0C or 39.0–39.9C 1
36.1–38.9C 0
Hypotension 2
Acute hypotensive event with
drop in systolic blood pressure
>30 mmHg and diastolic blood
pressure >20 mmHg or Require-
ment for intravenous vasopressor











Minor criteria 2 minor or
1 major
[9]
Systolic BP <90 mmHga
Multilobar involvement (>2 lobes)a
Pa02/Fi02 ratio (<250)a
Major criteria
Requirement for mechanical venti-
lationa
Septic shocka















Requirement for mechanical venti-
lationa
Septic shocka
CURB-65 Confusiona ‡3 [3]
Urea (>7 mmol/L)a,
Respiratory rate (‡30/min)a,
Blood pressure (systolic <90 or
diastolica £60 mmHg, and
age ‡65 yearsa
CRB-65 As above without urea variable ‡3 [4]
PSI Uses 20 variables including age,
gender, co-morbidity, vital sign
abnormalities and several labora-
tory and radiographic parameters
IV or V [2]
aAll criteria are graded within 48 h before or on the day of ﬁrst positive blood
culture. The highest point score during that time is recorded.
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between the PSI, CURB-65 and IDSA/ATS (p >0.20, NS)
(Figs 1 and 2).
Mortality prediction by scoring system and ICU admission
Assuming that ICU care improves outcome in severely-ill
patients, we would expect patients successfully identiﬁed as
severely-ill to have a lower mortality if admitted to an ICU.
Severely-ill patients as classiﬁed by the PBS and modiﬁed-
ATS were found to have better outcomes if they had been
admitted to the ICU. Speciﬁcally, of 766 patients evaluated
by the PBS, 16.3% (125/766) were classiﬁed as severely ill.
Of these, 78 were admitted to the ICU with a 14-day mor-
tality of 37.2% (29/78) as compared with 47 severely-ill
patients not admitted to the ICU with a 14-day mortality of
85.1% (40/47) (p <0.0003) (Table 4, Fig. 3). Of the 766
patients evaluated using the modiﬁed-ATS criteria, 27.5%
(211/766) were classiﬁed as severely ill. These severely-ill
patients also had signiﬁcantly better outcome if they were
admitted to the ICU (Table 4, Fig. 3).
The CURB-65, CRB-65, IDSA/ATS guidelines and PSI scor-
ing systems proved not to be useful in identifying those
patients who would beneﬁt from ICU care. Of the 744
patients evaluated by the CURB-65, 24.6% (183/744) were
classiﬁed as severely ill. The mortality of those admitted to
the ICU (29.9%) was similar to those not admitted to the
ICU (31.1%) (Table 4, Fig. 3). If the cut-point was raised to
TABLE 2. Summary of sensitivity, speciﬁcity, positive predictive value and negative predictive value for ﬁve severity of illness
scoring systems. Laboratory parameters that were missing were assumed to be normal, where feasible. For patients with
missing values in which a normal value could not be used (usually age), the patient was excluded (n = 739)
Score system Sensitivity Speciﬁcity Positive predictive value Negative predictive value Correctly classiﬁed
PBS > 4 61.3% (65/106) 91.3% (578/633) 54.2% (65/120) 93.4% (578/619) 87.0% (643/739)
Modiﬁed-ATS 72.6% (77/106) 80.2% (508/633) 38.1% (77/202) 94.6% (508/537) 79.2% (585/739)
IDSA/ATS 79.2% (84/106) 66.0% (418/633) 28.1% (84/299) 95.0% (418/440) 67.9% (502/739)
CURB-65 ‡ 3 52.8% (56/106) 80.1% (507/633) 30.8% (56/182) 91.0% (507/557) 76.2% (563/739)
PSI IV or V 80.2% (85/106) 55.6% (352/633) 23.2% (85/366) 94.4% (352/373) 59.1% (437/739)
TABLE 3. Summary of data as in Table 2, after exclusion of those patients in whom any parameters were missing (n = 519)
Score system Sensitivity Speciﬁcity Positive predictive value Negative predictive value Correctly classiﬁed
PBS > 4 59.5% (44/74) 90.1% (401/445) 50% (44/88) 93.0% (401/431) 85.7% (445/519)
Modiﬁed-ATS 73.0% (54/74) 76.6% (342/445) 34.3% (54/157) 94.5% (342/362) 76.3% (396/519)
IDSA/ATS 83.8% (62/74) 58.2% (259/445) 25% (62/248) 95.6% (259/271) 61.8% (321/519)
CURB-65 ‡ 3 58.1% (43/74) 77.6% (345/445) 30.1% (43/143) 91.8% (345/376) 74.8% (388/519)
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PBS ROC area: 0.8195 CRB-65 ROC area: 0.703
CURB-65 ROC area: 0.6675 PSI ROC area: 0.5523
Mod-ATS ROC area: 0.5538 IDSA/ATS ROC area: 0.5313
Reference
FIG. 1. Receiver-operating curves (ROC) for
patients admitted to the intensive care unit
(ICU). PBS, Pitt Bacteraemia Score; Mod-ATS,
Modiﬁed-ATS; PSI, Pneumonia Severity Index.
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‡4, then 30 severely-ill patients were noted to have been
admitted to the ICU with a mortality of 36.7% (11/30) as
compared with a mortality of 51.9% (14/27) (p >0.20, NS).
Results were similar for CRB-65 (Table 4, Fig. 3) (p >NS).
Of the 766 patients evaluated by the IDSA/ATS guidelines,
40.6% (311/766) were classiﬁed as severely ill. The mortality
of those admitted to the ICU, 25.8% (33/128), was similar to
those not admitted to the ICU, 30.6% (56/183) (Table 4,
Fig. 3). Of the 742 patients evaluated using the PSI, 49.5%
(367/742) were classiﬁed as severely ill. The PSI score per-
formed poorly (Table 4, Fig. 3).
To rule out the possibility that the superiority of the PBS
or modiﬁed-ATS was artifactually as a result of the fact that
one of the parameters included mechanical ventilation, the
SOI scores were re-calculated after removing mechanical
ventilation as a parameter. There was no signiﬁcant differ-
ence in conclusions (data not shown). The PBS remained the
most speciﬁc with the highest PPV.
In order to minimize the possibility that some cases,
accurately classiﬁed as severely-ill patients by the SOI scor-
ing system, may not have been admitted to the ICU
because of confounding factors, we excluded 78 patients
who had been listed as ‘Do Not Resuscitate’ (DNR).
Regardless, the PBS and modiﬁed-ATS remained the most
accurate SOI score. As patients from South Africa and HIV-
positive patients were possibly less likely to be admitted to
the ICU overall, we also excluded all South African patients
and HIV-positive patients from further analyses. Regardless,
TABLE 4. Patients stratiﬁed by SOI scoring system and
mortality (ICU vs. no ICU)
Score Percent of total
Mortality
p-ValueICU No ICU
PBS 16.3% (125/766) 37.2% (29/78) 85.1% (40/47) 0.0003
Mod-ATS 27.5% (211/766) 26.7% (31/116) 52.6% (50/95) 0.0001
IDSA ATS 40.6% (311/766) 25.8% (33/128) 30.6% (56/183) NS
CURB-65 4–5 7.7% (57/744) 36.7% (11/30) 51.9% (14/27) NS
CURB-65 3–5 24.6% (183/744) 29.9% (23/77) 31.1% (33/106) NS
CRB-65 3–5 9.9% (74/744) 38.9% (14/36) 50% (19/38) NS
PSI IV–V 49.5% (367/742) 25% (26/104) 22.4% (59/263) NS
Per cent of total, per cent classiﬁed as ‘severely-ill’ in the total study population;
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PBS ROC area: 0.8397 CRB-65 ROC area: 0.7365
CURB-65 ROC area: 0.7361 PSI ROC area: 0.721
Mod-ATS ROC area: 0.7491 IDSA/ATS ROC area: 0.7099
Reference
FIG. 2. Receiver-operating curves (ROC) for
all patients. PBS, Pitt Bacteraemia Score; Mod-
ATS, Modiﬁed-ATS; PSI, Pneumonia Severity
Index.
TABLE 5. Comparison of severity of illness scoring systems
related to mortality as in Table 4, but with exclusion of ‘Do








PBS £4 5.7% (3/53) 4.0% (13/322) NS
>4 28.1% (16/57) 77.8% (7/9) 0.007
Mod-ATS 0 10.0% (2/20) 3.4% (10/293) NS
1 18.9% (17/90) 26.3% (10/38) NS
IDSA/ATS 0 0/10 3.0% (7/231) NS
1 20.7% (18/87) 16.7% (9/54) NS
PSI £3 13.0% (3/23) 1.2% (2/164) 0.014
4–5 19.0% (16/84) 11.6% (18/155) NS
CURB-65 £3 13.2% (11/83) 5.5% (17/308) 0.028
4–5 33.3% (8/24) 23.1% (8/13) NS
Only PBS selects patients that beneﬁt from ICU admission when these three
patient groups are excluded. PBS, Pitt Bacteraemia Score; Mod-ATS, Modiﬁed-
ATS; PSI, Pneumonia Severity Index.
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PBS was again the most accurate scoring system (Table 5).
HIV positivity had little impact on the SOI scoring systems
(data not shown).
Analyses were repeated for an endpoint of 30-day mortal-
ity; PBS was the most accurate scoring system (data not
shown). There were only ten additional deaths between day
14 and day 30.
Discussion
In this study, we focused on three well-established scoring
systems for CAP, CURB-65, PSI and the modiﬁed-ATS
scoring systems [10–20] and compared those with the IDSA/
ATS guidelines and the PBS (Table 1). Patients with pneumo-
coccal bacteraemia have special relevance to CAP because
Streptococcus pneumoniae is the most frequently identiﬁable
cause of CAP and carries a notably high mortality [20]. The
PBS was designed for use in bacteraemia and its efﬁcacy
has been validated for bloodstream infections caused by
S. pneumoniae [8] and other organisms [7].
In our study, the PBS had the highest speciﬁcity (91.3%) as
compared with the CURB-65 (80.1%) and PSI (55.6%)
(Table 2). The sensitivities of the PSI (80.2%) and the IDSA/
ATS guidelines (79.2%) were higher than those of the
CURB-65 (52.8%), the modiﬁed-ATS (72.6%) and the PBS
(61.3%) (Table 2). Theoretically, the scoring system that
gives the maximal sensitivity should minimize the number of
deaths, as a larger number of patients would be identiﬁed as
requiring ICU care.
However, ICU bed availability varies worldwide and is fre-
quently a limiting factor. SOI scores that accurately identify
those cases that truly would beneﬁt from ICU care thus
become most important. In this respect, the PPV appears to
be more important in this situation as it deﬁnes the propor-
tion of the patients classiﬁed as severely-ill who actually die.
Thus, the PPV as a criterion becomes a relevant clinical
parameter in the real world. On the basis of the PPV, the
PBS was superior to the other scoring systems (Tables 2 and
3). For the PSI, the PPV of only 23.2% essentially rendered it
unusable as a decision-making parameter (Table 2). ICU care
would be expected to improve outcome in severely-ill
patients, and so we ascertained the mortality for severely-ill
patients as classiﬁed by each SOI scoring system, according to
whether the patients had been admitted to an ICU. Almost
one-half of the patients were classiﬁed as severely-ill by the
PSI (49.5%) and the IDSA/ATS guidelines (40.6%). For both
the PSI and CURB-65, there was no signiﬁcant difference in
survival between those patients classiﬁed as severely-ill by
these scoring systems who were actually admitted to the ICU
and those who were not (Results, Table 4, Fig. 3). The CRB-
65 (criteria 3–5) classiﬁed only 9.9% as severely-ill and was
inaccurate in predicting which patients would beneﬁt from
ICU care. On the other hand, Fig. 3 shows that the PBS and
modiﬁed-ATS criteria were accurate in predicting which
patients would most beneﬁt from ICU care. This ﬁnding for
PBS and modiﬁed-ATS criteria supports the hypothesis that
severely-ill patients might beneﬁt from more intensiﬁed care
and monitoring (Table 4, Fig. 3). To minimize biases concern-
ing non-admission of severely-ill patients to the ICU, we
excluded three groups of patients. Patients classiﬁed as DNR
were excluded as they were deemed ‘terminal’. HIV status
and country of origin (South Africa) might affect decisions for
ICU admission, so these patients were also excluded. PBS
remained the most accurate score (Table 5).
The PBS had signiﬁcantly more discriminatory power, as
measured by the ROC, than the CURB-65 (Figs 1 and 2).
The accuracy of the PBS in predicting mortality in pneumo-
coccal bacteraemia has been documented in our initial study
[8]. In fact, when conﬁned to patients who were admitted to
the ICU, it was superior to the acute physiology and chronic
health evaluation (APACHE) score in predicting mortality
(although this difference was not statistically signiﬁcant). This
is somewhat surprising given the ease and simplicity of calcu-
lation of the PBS, compared with the large number of param-
eters used for APACHE scoring.
In addition to this prospective study, two studies have
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FIG. 3. Patients stratiﬁed by severity of illness scoring systems and
mortality [intensive care unit (ICU) vs. no ICU]. The histogram
represents mortality in patients not admitted to the ICU minus
mortality in patients admitted to the ICU. The higher the improve-
ment in per cent mortality between ICU care vs. no ICU care, the
more useful the SOI score is for clinicians. PBS, Pitt Bacteraemia
Score; ATS, Modiﬁed-ATS criteria; PSI, Pneumonia Severity Index;
IDSA/ATS, Infectious Diseases Society of America/American
Thoracic Society guidelines.
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a prospective and retrospective Swedish study of 114
patients with pneumococcal pneumonia who were shown to
have bacteraemia [21] and a retrospective American study of
151 patients (of whom 69 were conﬁrmed to have bactere-
mia) [22]. The PSI had high sensitivity in both studies (89–
100%), variable speciﬁcity (17–60%) and low PPV (7–25%).
The CURB-65 had variable sensitivity (22–62%), high speciﬁc-
ity (86–97%) and variable PPV (33–36%). In 1339 patients
with community-acquired pneumonia from the PORT Study,
both the PSI and the modiﬁed-ATS criteria had poor PPV
and low speciﬁcity [5]. The British Thoracic Society criteria
performed even more poorly than the modiﬁed-ATS criteria.
In a study of 696 patients with community-acquired pneu-
monia, the PPV of the modiﬁed-ATS was notably higher than
that of the British Thoracic Society scoring system and
CURB-65 [9]. In a Spanish prospective observational study of
457 patients with community-acquired pneumonia, the modi-
ﬁed-ATS criteria were more accurate than the PSI or
CURB-65 for predicting ICU admission and mortality [23]. In
a prospective observational study of 1016 patients in Hong
Kong with community-acquired pneumonia, PSI, CURB-65
and CRB-65 had high NPV, but low PPV. The authors
concluded that CURB-65 was preferable to CRB-65 and PSI
in the emergency room setting [24].
Our study has a number of strengths, including the large
number of patients, and the prospective nature of the data
collection. For each of the SOI scoring systems, we also cal-
culated the mortality rate of patients admitted to the ICU
compared with that of patients not admitted to the ICU, a
unique analysis of efﬁcacy not previously reported (Fig. 3).
This analysis should be useful in evaluating the utility of an
SOI scoring system. We are aware that ICU care is not uni-
versally available throughout the world. In these situations
intensiﬁcation of care outside an ICU setting may still be fea-
sible. Such care may include more frequent monitoring, opti-
mal administration of parenteral antibiotics and intensiﬁed
supportive care.
The major weakness of this study is that our study group
was conﬁned to patients with pneumococcal bacteraemia.
On the other hand, S. pneumoniae, the most common cause
of CAP, carries a notably higher mortality than other com-
mon pathogens (with the exception of Legionella) and is the
most common pathogen identiﬁed in cases of pneumonia
admitted to the ICU. Moreover, we cannot help but note
that the CURB-65, CRB-65, IDSA/ATS guidelines and PSI
performed poorly for the largest group of patients most
likely to die from CAP.
Further research could improve the accuracy of the SOI
scores. For example, perusal of Table 4 and Fig. 3 shows that
a CURB-65 cut-point of 4–5 may be preferable to the origi-
nal cut-point of ‡3 initially used by the authors in their ﬁrst
report [3,25].
Simplicity is a virtue. Thus, our ﬁnding that the results
generated by CRB-65 in which the uraemia parameter is
omitted were as accurate as the CURB-65 score is clinically
relevant (Figs 1–3). Similarly, PBS was more accurate than
modiﬁed-ATS criteria and IDSA/ATS guidelines, without the
requirement for the arterial PO2 (Tables 2 and 3). Finally,
both the modiﬁed-ATS criteria and IDSA/ATS guidelines are
a bit more complex (with the use of major and minor crite-
ria) and are presented as dichotomous scores: severely ill vs.
not severely ill. In contrast, the PSI, CURB-65 and PBS are
cumulative numerical scores. As the PBS increases above
four, the likelihood of death increases signiﬁcantly
(p <0.0001) (data not shown). Thus, the absolute magnitude
of the PBS may be useful if ICU resources are scarce. For
example, ICU admission might be futile for patients with
inordinately high scores. The modiﬁed-ATS criteria and
IDSA/ATS guidelines cannot be applied in this way. The use
of the PSI should be conﬁned to assessing the decision for
outpatient therapy vs. hospital admission; it was not designed
to be a SOI scoring system.
Socioeconomic factors and personal choices are often
taken into consideration in management, in addition to the
risk of death. For patients with pneumonia of greater
severity, an accurate severity of illness scoring system
weighs heavily. If socioeconomic circumstances, personal
choice and bed availability become the pivotal factors for
decision-making for ICU admission (or admission to a non-
ICU area with intensiﬁed surveillance and care), an accurate
severity of illness scoring system such as the PBS can give
an objective assessment for the consequences of such a
decision. The ability of PBS to deﬁne accurately patients at
high risk and who would beneﬁt from ICU care, plus its
unusual degree of simplicity, should prompt ongoing evalua-
tion of this scoring system in studies of CAP. Future
prospective comparative studies of CAP using the modiﬁed-
ATS criteria, IDSA/ATS guidelines, CURB-65 and PBS are
indicated to conﬁrm the observations from this study. Most
studies of SOI have concluded that clinical judgment is nec-
essary and that the SOI scores serve only as adjunctive
information to assist the physician in decision-making.
Subjective assessments of socioeconomic and personal fac-
tors need to be made by the human clinician. On the other
hand, an objective accurate scoring system which predicts
which patients will be most likely to beneﬁt from ICU care
would be useful. The PBS or modiﬁed-ATS criteria appear
to select accurately patients who would beneﬁt from inten-
siﬁed care as opposed to standard care in a hospital ward
setting (Fig. 3).
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Appendix
International Pneumococcal Study Group: Argentina: Hospital
de Clinicas: Carlos M. Luna, MD (PI), Ricardo Mosquera,
MD, Carmen de Mier, PhD, Angela Famiglietti, PhD, Carlos
Vay, PhD, Hospital Santmarina: Jorge Gentile, MD, Monica
Sparo, PhD Brazil: 5Universidade Federal de Cieˆncias da Sa-
u´de de Porto Alegre and Santa Casa de Miserico´rdia de
Porto Alegre: Maria Bernadete F. Chedid, MD (PI), Cicero
Dias, PhD; Hospital de Clinicas de Porto Alegre: Afonso L.
Barth, PhD; Hospital N.S. da Conceic¸a˜o: Breno Riegel dos
Santos, MD; France: Hospital Bichat-Claude Bernard: Antoine
Andremont, MD (PI); Karine Grenet, Pharm D., Hyam Moun-
ieme, MD, Hong Kong: Chinese University of Hong Kong:
David Hui, MD (PI), Margaret Ip, MD, Donald Lyon, MD,
New Zealand: Auckland Hospital: Arthur J. Morris, MD, (PI),
Sally A. Roberts, MB, ChB, Dragana Drinkovic, MD, Susan L.
Taylor, MB, ChB. South Africa: Charlotte Maxeke Johannesburg
Hospital, Johannesburg: Charles Feldman, MB, PhD (PI), Keith
P. Klugman, MD, PhD (Co-PI); Anne van Gottberg, MB,
Xoliswa Poswa, MB, Rajen Morar, MB. Spain: University Hos-
pital Joan XXIII, University Rovira and Virgilli, Tarragona: J.
Rello, MD (PI), Miquel Gallego, MD, M. Lujan, MD, Emili
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